Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
Effective as of
The foregoing description of the Bylaws is not complete and is qualified in its entirety by reference to the full text of the Bylaws, as amended and restated, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
On
Stock may be repurchased in open market or in privately negotiated transactions, and the amount and timing of any repurchases, will be dependent on various factors, including market conditions and corporate and regulatory considerations. Omega intends to finance any stock repurchases through cash flow from operations, balance sheet cash, planned asset sales, and/or borrowings under Omega's revolving credit facility.
The information furnished in Exhibit 99.1, shall not be deemed "filed" for any purpose, including for the purposes of the Exchange Act, or otherwise subject to the liabilities of that Section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No. Description of Exhibit
3.1 Amended and Restated Bylaws ofOmega Healthcare Investors, Inc. , as ofJanuary 27, 2022 99.1 Press Release datedJanuary 27, 2022 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source